Navigation Links
Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
Date:11/15/2011

NEW YORK, Nov. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market

http://www.reportlinker.com/p0368716/Bristol-Myers-Squibb-Performance-Capabilities-Goals-and-Strategies-in-the-Worldwide-Pharmaceutical-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

A strategic assessment of Bristol-Myers Squibb, one of the world's leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global pharmaceutical market.

Contains 88 pages and 20 tables

Table of Contents

I. Executive Summary . . . 1

II. Business Organization 5

III. Senior Management . . 14

IV. Facilities and Employees . 18

V. Technological Know-How 21

VI. Product Portfolio . 23

VII. Marketing Tactics 31

VIII. Sales and Profit Growth . 33

IX. R&D Expenditures and Major Programs . 55

X. Collaborative Arrangements . 60

XI. Strategic Direction . . 84

List of Tables

Table 1: Bristol-Myers Squibb Sales and Operating Profit

Growth

Table 2: Bristol-Myers Squibb Sales By Major Drug and Geographic Region

Table 3: Bristol-Myers Squibb Sales Growth by Major Drug

Table 4: Bristol-Myers Squibb Sales By Geographic Region

Table 5: Bristol-Myers Squibb Estimated Sales Growth By Geographic Region

Historical Financials

Table 1: Bristol-Myers Squibb Sales and Operating Profit

Growth

Table 2: Bristol-Myers Squibb Sales by Major Division

Table 3: Bristol-Myers Squibb Sales by Major Division and

Geographic Region

Table 4: Bristol-Myers Squibb Sales Growth by Major Division

Table 5: Bristol-Myers Squibb Sales by Therapeutic Category

Table 6: Bristol-Myers Squibb Sales by Therapeutic Category

and Geographic Region

Table 7: Bristol-Myers Squibb Sales Growth by Therapeutic

Category

Table 8: Bristol-Myers Squibb Sales by Major Drug

Table 9: Bristol-Myers Squibb Sales Growth by Major Drug

Table 10: Bristol-Myers Squibb Sales by Product Line

Table 11: Bristol-Myers Squibb Sales Growth by Product Line

Table 12: Bristol-Myers Squibb Sales by Geographic Region

Table 13: Bristol-Myers Squibb Sales Growth by Geographic

Region

Table 14: Bristol-Myers Squibb Other Health Care Sales by

Product

Table 15: Bristol-Myers Squibb Sales Growth by Geographic Region

To order this report:

: Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market

More  Market Research Report

Check our  Real Time Industry Data

CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
2. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
3. Top Bristol-Myers Squibb Executive Joins Patton Boggs
4. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
5. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
6. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
7. Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
8. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
9. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
10. GNS Healthcare Announces Collaboration With Bristol-Myers Squibb
11. The Oclaro Next-Generation Orion Fiber-Coupled Diode Laser Raises the Bar for Performance, Cost and Reliability for Solid State Lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):